Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
URB1 antisense RNA 1 (URB1-AS1) is a long non-coding RNA (lncRNA) located on chromosome 12 or 21, described as an antisense transcript to the URB1 locus[1][2]. It does not encode a protein but is involved in the regulation of gene expression through ceRNA mechanisms and transcriptional modulation. URB1-AS1 has been implicated in cellular processes such as proliferation, apoptosis, and migration. Its dysregulation has been reported in various cancers, where it may function either as a tumor promoter or suppressor depending on context. Its complex and context-dependent roles are still under investigation, and it is not currently considered a conventional therapeutic target such as a receptor, enzyme, or transporter[2].
Acts as a competing endogenous RNA (ceRNA) sponging microRNAs, regulation of gene expression at the transcriptional level[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on URB1 antisense RNA 1 (URB1-AS1).